PegBio
Hangzhou, CN · 1 known investors
Find your way into PegBio
PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders. Using its proprietary HECTOR technology platform, it designs peptide, protein, and small-molecule drug candidates targeting conditions such as type 2 diabetes, obesity, MASH, opioid-induced constipation, and congenital hyperinsulinism.
Investors · 1
In the news
3 Small Cap Biotech Stocks Trading At A Discount With Late Stage Clinical Catalystsfinance.yahoo.com · Aug 2026
Rani Therapeutics Q2 Earnings: $8.4M Net Loss | RANI Stock Newsstocktitan.net · Aug 2026
Lexaria Enters a Material Transfer Agreement With PegBio | INNinvestingnews.com · Aug 2026Frequently asked questions
- What does PegBio do?
- PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders. Using its proprietary HECTOR technology platform, it designs peptide, protein, and small-molecule drug candidates targeting conditions such as type 2 diabetes, obesity, MASH, opioid-induced constipation, and congenital hyperinsulinism.
- Who are PegBio's investors?
- PegBio's investors include YuanBio Venture Capital.
- Where is PegBio headquartered?
- PegBio is headquartered in Hangzhou, CN.